Assembled tau filaments differ from native paired helical filaments as determined by scanning transmission electron microscopy (STEM)

Brain Research

Volumn 814, Issue 1-2, 1998, Pages 86-98

  Ksiezak Reding, Hanna ^a   Yang, Guodze ^a   Simon, Martha ^b   Wall, Joseph S ^b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b BROOKHAVEN NATIONAL LABORATORY   (United States)

Author keywords

Assembled tau filaments; Mass density; Neurodegenerative disorders; Paired helical filaments; Scanning transmission electron microscopy; Ultrastructure

Indexed keywords

TAU PROTEIN;

ALZHEIMER DISEASE; ARTICLE; DNA HELIX; GENE FREQUENCY; HUMAN; HUMAN CELL; NERVE DEGENERATION; NEUROFILAMENT; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN PHOSPHORYLATION; RECEPTOR DENSITY; SCANNING ELECTRON MICROSCOPY; TRANSMISSION ELECTRON MICROSCOPY; ULTRASTRUCTURE;

ALZHEIMER DISEASE; HUMANS; MICROSCOPY, ELECTRON, SCANNING TRANSMISSION; NEURODEGENERATIVE DISEASES; NEUROFIBRILLARY TANGLES; PHOSPHORYLATION; RECOMBINANT PROTEINS; TAU PROTEINS;

EID: 0032517796     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)01052-X     Document Type: Article

References (59)

1. Arrasate M., Perez M., Valpuesta J.M., Avila J. Role of glycosaminoglycans in determining the helicity of paired helical filaments. Am. J. Pathol. 151:1997;1115-1122.
2. Bradford M.M. A rapid and sensitive method for the quantization of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
3. Carmel G., Mager E.M., Binder L.I., Kuret J. The structural basis of monoclonal antibody Alz50's selectivity for Alzheimer's disease pathology. J. Biol. Chem. 271:1996;32789-32795.
4. Cleveland D.W., Hwo S.-Y., Kirschner M.W. Physical and chemical properties of purified tau factor and the role of tau in microtubule assembly. J. Mol. Biol. 116:1977;227-247.
5. Conrad C., Andreadis A., Trojanowski J.Q.et al. Genetic evidence for the involvement of tau in progressive supranuclear palsy. Ann. Neurol. 41:1997;277-281.
6. Crowther R.A. Review. Structural aspects of pathology in Alzheimer's disease. Biochim. Biophys. Acta. 1096:1991;1-9.
7. Crowther R.A., Olesen O.F., Smith M.J., Jakes R., Goedert M. Assembly of Alzheimer-like filaments from full-length tau protein. FEBS Lett. 337:1994;135-138.
8. A. Ducruix, R. Giege, (Eds.), Crystallization of Nucleic Acids and Proteins. A Practical Approach, IRL Press, Oxford Univ. Press, New York, 1992, pp. 82-89.
9. Feany M.B., Dickson D.W. Widespread cytoskeletal pathology characterizes corticobasal degeneration. Am. J. Pathol. 146:1995;1388-1396.
10. Feany M.B., Ksiezak-Reding H., Liu W.-K., Vincent I., Yen S.-H., Dickson D.W. Epitope expression and hyperphosphorylation of tau proteins in corticobasal degeneration: differentiation from progressive supranuclear palsy. Acta Neuropathol. 90:1995;37-43.
11. Flament S., Delacourte A., Verny M., Hauw J.-J., Javoy-Agid F. Abnormal tau proteins in progressive supranuclear palsy. Similarities and differences with the neurofibrillary degeneration of the Alzheimer type. Acta Neuropathol. 81:1991;591-596.
12. Gibson G., Martins R., Blass J.P., Gandy S. Altered oxidation and signal transduction systems in fibroblasts from Alzheimer patients. Life Sci. 59:1996;477-489.
13. Goedert M., Spillantini M.G., Jakes R., Rutherford D., Crowther R.A. Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease. Neuron. 3:1989;519-526.
14. Goedert M., Spillantini M.G., Potier M.C., Ulrich J., Crowther R.A. Cloning and sequencing of the cDNA encoding an isoform of microtubule-associated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain. EMBO J. 8:1989;393-399.
15. Goedert M., Spillantini M.G., Hasegawa M., Jakes R., Crowther R.A., Klug A. Molecular dissection of the neurofibrillary lesions of Alzheimer's disease. Cold Spring Harbor Symp. Quant. Biol. 61:1996;565-573.
16. Goedert M., Jakes R., Spillantini M.G., Hasegawa M., Smith M.J., Crowther R.A. Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans. Nature. 383:1996;550-553.
17. Greenberg S.G., Davies P. A preparation of Alzheimer paired helical filaments that displays distinct tau proteins by polyacrylamide gel electrophoresis. Proc. Natl. Acad. Sci. USA. 187:1990;5827-5831.
18. Grundke-Iqbal I., Iqbal K., Tung Y.C., Ouinlan M., Wisniewski H.M., Binder L.I. Abnormal phosphorylation of the microtubule-associated protein tau in Alzheimer cytoskeletal pathology. Proc. Natl. Acad. Sci. USA. 83:1986;4913-4917.
19. Hagestedt B., Lichtenberg B., Wille H., Mandelkow E.M., Mandelkow E. Tau protein becomes long and stiff upon phosphorylation: correlation between paracrystalline structure and degree of phosphorylation. J. Cell Biol. 109:1989;1643-1651.
20. Himmler A. Structure of bovine tau gene: alternatively spliced transcripts generate a protein family. Mol. Cell. Biol. 9:1989;1389-1396.
21. Hirokawa N., Shiomura Y., Okabe S. Tau proteins: their molecular structure and mode of binding on microtubules. J. Cell Biol. 107:1988;1449-1459.
22. Hutton M., Lendon C.L., Rizzu P., Baker M., Froelich S., Houlden H.et al. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature. 393:1998;702-705.
23. Ikonomovic M.D., Armstrong D.M., Yen S.-H., Obcemea C., Vidic B. Atomic force microscopy of paired helical filaments from the autopsied brains of patients with Alzheimer's disease and immunolabeled against microtubule-associated proteins tau. Am. J. Pathol. 147:1995;516-528.
24. Kampers T., Friedhoff P., Biernat J., Mandelkow E.-M., Mandelkow E. RNA stimulates aggregation of microtubule-associated protein tau into Alzheimer-like paired helical filaments. FEBS Lett. 399:1996;344-349.
25. Kato S., Nakamura H. Presence of two different fibril subtypes in the Pick body: an immunoelectron microscopic study. Acta Neuropathol. 81:1990;125-129.
26. Kidd M. Paired helical filaments in electron microscopy of Alzheimer's disease. Nature. 197:1963;192-193.
27. Ksiezak-Reding H., Wall J.S. Mass and physical dimensions of two distinct populations of paired helical filaments. Neurobiol. Aging. 15:1994;11-19.
28. Ksiezak-Reding H., Liu W.-K., Yen S.-H. Phosphate analysis and dephosphorylation of modified tau associated with paired helical filaments. Brain Res. 597:1992;209-219.
29. Ksiezak-Reding H., Morgan K., Weidenheim K., Mattiace L.A., Liu W.K., Yen S.H., Davies P., Dickson D.W. Ultrastructure and biochemical composition of paired helical filaments in corticobasal degeneration. Am J. Pathol. 145:1994;1496-1508.
30. Ksiezak-Reding H., Leibowitz R.L., Bowser R., Davies P. Binding of Alz 50 depends on Phe8 in tau synthetic peptides and varies between native and denatured tau proteins. Brain Res. 697:1995;63-75.
31. Ksiezak-Reding H., Shafit-Zagardo B., Yen S.-H. Differential expressions of exon 10 and 11 in normal tau and tau associated with paired helical filaments. J. Neurosci. Res. 41:1995;583-593.
32. Ksiezak-Reding H., Tracz E., Yang L.-S., Dickson D.W., Simon M., Wall J.S. Ultrastructural instability of paired helical filaments from corticobasal degeneration as examined by scanning transmission electron microscopy. Am. J. Pathol. 149:1996;639-652.
33. Ledesma D.M., Bonay P., Avila J. Tau protein from Alzheimer's disease patients is glycated at its tubulin-binding domain. J. Neurochem. 65:1995;1658-1664.
34. Lindwall G., Cole R.D. The purification of tau proteins and the occurrence of two phosphorylation states of tau in brain. J. Biol. Chem. 259:1984;12241-12245.
35. 2+ influx in cultured hippocampal neurons. Neuron. 2:1990;105-117.
36. Matsuo E.S., Shin R.W., Billingsley M.L., Van de Voorde A., O'Connor M., Trojanowski L.Q., Lee V.M.Y. Biopsy-derived adult human brain tau is phosphorylated at many of the same sites as Alzheimer's disease paired helical filament tau. Neuron. 13:1994;989-1002.
37. McLaughlin L., Zelman F.P., Dean G.E. Identification of microtubule-associated protein tau isoforms in Alzheimer's paired helical filaments. Brain Res. 43:1997;501-508.
38. Miyakawa T., Katsuragi S., Araki K., Hashimura T., Kimura T., Kuramoto R. Ultrastructure of neurofibrillary tangles in Alzheimer's disease. Virschows Archiv. B Cell Pathol. 57:1989;267-273.
39. Mothes E., Shoeman R.L., Traub P. Pepstatin A: polymerization of an oligopeptide. Micron. 25:1994;189-217.
40. Paudel H.K. Phosphorylation by neuronal cdc2-like protein kinase promotes dimerization of tau protein in vitro. J. Biol. Chem. 272:1997;28328-28334.
41. Perez M., Valpuesta J.M., Medina M., Montejo de Garcini E., Avila J. Polymerization of tau into filaments in the presence of heparin: the minimal sequence required for tau-tau interaction. J. Neurochem. 67:1996;1183-1190.
42. Perry G., Siedlak S.L., Richey P., Kawai M., Cras P., Kalaria R.N., Galloway P.G., Scardina J.M., Cordell B., Greenberg B.D., Ledbetter S.R., Gambetti P. Association of heparan sulfate proteoglycan with the neurofibrillary tangles of Alzheimer's disease. J. Neurosci. 11:1991;3679-3683.
43. Pollanen M.S., Markiewicz P., Goh C. Paired helical filaments are twisted ribbons composed of two parallel and aligned components: image reconstruction and modeling of filaments structure using atomic force microscopy. J. Neuropathol. Exp. Neurol. 56:1997;79-95.
44. Ruben G.C., Iqbal K., Grundke-Iqbal I., Wisniewski H.M., Ciardelli T.L., Johnson J.E. The microtubule-associated protein tau forms a triple-stranded left-hand helical polymer. J. Biol. Chem. 266:1991;22019-22027.
45. Ruben G.C., Ciardelli T.L., Grundke-Iqbal I., Iqbal K. Alzheimer disease hyperphosphorylated tau aggregates hydrophobically. Synapse. 27:1997;208-229.
46. Schweers O., Schonbrunn-Hanebeck E., Marx A., Mandelkow E. Structural studies of tau protein and Alzheimer paired helical filaments show no evidence for β-structure. J. Biol. Chem. 269:1994;24290-24297.
47. Schweers O., Mandelkow E.-M., Biernat J., Mandelkow E. Oxidation of cysteine-322 in the repeat domain of microtubule-associated protein tau controls the in vitro assembly of paired helical filaments. Proc. Natl. Acad. Sci. U.S.A. 92:1995;8463-8467.
48. Selkoe D.J. Amyloid β-protein and the genetics of Alzheimer's disease. J. Biol. Chem. 271:1996;18295-18298.
49. Sergeant N., David J.P., Lefranc P., Vermersch P., Wattez A., Delacourte A. Different distribution of phosphorylated tau protein isoforms in Alzheimer's and Pick's diseases. FEBS Lett. 412:1997;578-582.
50. Snow A.D., Wight T.N. Proteoglycans in the pathogenesis of Alzheimer's disease. Neurobiol. Aging. 10:1989;481-497.
51. Snow A.D., Sekiguchi R., Nochlin D., Kalaria R.N., Kimata K. Heparan sulfate proteoglycan in diffuse plaques of hippocampus but not in cerebellum of Alzheimer's disease brain. Am. J. Pathol. 144:1994;337-347.
52. Troncoso J.C., Costello A., Watson A.L., Johnson G.V.W. In vitro polymerization of oxidized tau into filaments. Brain Res. 613:1993;313-316.
53. 2+-binding protein ALG-2 and Alzheimer's disease gene ALG-3. Science. 271:1996;521-525.
54. Wall J.S., Hainfeld J.F. Mass mapping with the scanning transmission electron microscope. Annu. Rev. Biophys. Chem. 15:1986;355-376.
55. Wille H., Drewes G., Biernat J., Mandelkow E.-M., Mandelkow E. Alzheimer-like paired helical filaments and antiparallel dimers formed from microtubule-associated protein tau in vitro. J. Cell Biol. 118:1992;573-584.
56. Wilson D.M., Binder L.I. Polymerization of microtubule-associated protein tau under near-physiological conditions. J. Biol. Chem. 270:1995;24306-24314.
57. Wilson D.M., Binder L.I. Free fatty acids stimulate the polymerization of tau and amyloid B peptides: in vitro evidence for a common effector of pathogenesis in Alzheimer's disease. Am. J. Pathol. 150:1997;2181-2195.
58. Wisniewski H.M., Wen G.Y. Substructure of paired helical filaments from Alzheimer's disease neurofibrillary tangles. Acta Neuropathol. 66:1985;173-176.
59. Yan S.D., Chen X., Schmidt A.M., Brett J., Godman G., Zou Y.S., Scott C.W., Caputo C., Frappier T., Smith M.A., Perry G., Yen S.H., Stern D. Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress. Proc. Natl. Acad. Sci. USA. 91:1994;7787-7791.